advertising
-
1
Stone JH: Polyarteritis nodosa. JAMA 288: 1632, 2002.
-
2
Matteson EL: A history of early investigation in polyarteritis nodosa. Arthritis Care Res 12: 294, 1999.
-
3
Rott KT: “Polyarteritis Nodosa,” in Primer on the Rheumatic Diseases , 13th Ed, edited by JH Klippel, JH Stone, LJ Crofford, et al, p 410, Springer, New York, 2008.
-
4
Guillevin L, Cohen P, Mahr A, et al: Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 49: 93, 2003.
-
5
Guillevin L, Lhote F, Jarrousse B, et al: Polyarteritis nodosa related to hepatitis B virus: a retrospective study of 66 patients. Ann Med Interne (Paris) 143: 63, 1992.
-
6
The Vasculitis Foundation: Polyarteritis nodosa. Available at: http://www.vasculitisfoundation.org/education/forms/polyarteritis-nodosa/. Accessed May 16, 2016.
-
7
Saadoun D, Terrier B, Semoun O, et al: Hepatitis C virus-associated polyarteritis nodosa. Arthritis Care Res 63: 427, 2011.
-
8
Ventura F, Antunes H, Brito C, et al: Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination. Eur J Dermatol 19: 400, 2009.
-
9
De Keyser F, Naeyaert JM, Hindryckx P, et al: Immune-mediated pathology following hepatitis B vaccination: two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 18: 81, 2000.
-
10
Bourgeais AM, Dore MX, Croue A, et al: Cutaneous polyarteritis nodosa following hepatitis B vaccination. Ann Dermatol Venereol 130: 205, 2003.
-
11
Lightfoot RW, Michel BA, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33: 1088, 1990.
-
12
De Carvalho JF, Pereira RM, Shoenfeld Y: Systemic polyarteritis following hepatitis B vaccination. Eur J Intern Med 19: 575, 2008.
-
13
Begier EM, Langford CA, Sneller MC, et al: Polyarteritis nodosa reports to the Vaccine Adverse Event Reporting System (VAERS): implications for assessment of suspected vaccine-provoked vasculitis. J Rheumatol 31: 2181, 2004.
-
14
Institute of Medicine, Stratton K, Ford A, et al: “Hepatitis B Vaccine,” in Adverse Effects of Vaccines: Evidence and Causality , edited by K Stratton, A Ford, E Rusch, et al, p 865, National Academies Press, Washington, DC, 2012.
-
15
Silverman LJ: Collagen disease in podiatry. J Am Podiatry Assoc 52: 281, 1992.
-
16
Goldman EP, Stess RM: Rheumatoid vasculitis: a case report. J Am Podiatry Assoc 74: 514, 1984
-
17
Wagoner MR, Creech CL, Vlahovic TC: Idiopathic mixed small and medium vessel cutaneous vasculitis: a case report. Foot Ankle Online J 7: 5, 2014. doi: .Available at: http://faoj.org/wp-content/uploads/2014/03/vasculitis_final.pdf. Accessed June 5, 2016.
Polyarteritis Nodosa Following Vaccination Against Hepatitis B Virus with Lower-Extremity Manifestations: A Case Report
Search for other papers by Daniel R. Wright in
Current site
Google Scholar
PubMed
Search for other papers by Jenni M. Davis in
Current site
Google Scholar
PubMed
Search for other papers by Karl Robstad in
Current site
Google Scholar
PubMed
Search for other papers by Melissa D. Shah in
Current site
Google Scholar
PubMed
Search for other papers by Michael C. Keller in
Current site
Google Scholar
PubMed
Search for other papers by John R.L. Froude in
Current site
Google Scholar
PubMed
Polyarteritis nodosa is a progressive, often life-threatening, vasculitis affecting multiple organs, including the skin and peripheral nerves. We report a patient presenting with systemic features of the disease and with characteristic lesions in the feet 3 weeks after vaccination against hepatitis B virus infection.
advertising
